CIDP Diagnostic Pitfalls and Perception of Treatment Benefit
Neurol 85:498-504, Allen, J.A. & Lewis, R.A., 2015
Chronic Inflammatory Demyelinating Polyneuropathy Presenting with Features of GBS
Neurol 58:979-982, Mori,K.,et al, 2002
Hypertrophy of Multiple Cranial Nerves and Spinal Roots in Chronic Inflammatory Demyelinating Neuropathy
JNNP 67:685-687, Duarte,J.,et al, 1999
Differential Diagnosis of Guillain-Barre Synd, In Guillain-Barre Synd
Thieme Med Publ, Ch 3, p 42993., Parry,G.J., 1993
Evidence-based Guideline: Intravenous Immunoglobulin in the Treatment of Neuromascular Disorders
Neurol 78:1009-1015, Patwa,H.S.,et al, 2012
Natalizumab Treatment in a Patient With Chronic Inflammatory Demyelinating Polyneuropathy
Arch Neurol 67:881-883, Wolf,C., et al, 2010
Chronic Inflammatory Demyelinating Polyneuropathy: Etiology, Clinical Features, and Diagnosis
UpToDate, Sept, Lewis, R., 2010
Chronic Inflammatory Demyelinating Polyneuropathy
NEJM 352:1343-1356, Koller,H.,et al, 2005
Efficacy of Mycophenolate Mofetil in Patients with Chronic Immune Demyelinating Polyneuropathy
NEruol 63:715-717, Gorson,K.C.,et al, 2004
Clinical Spectrum of Chronic Acquired Demyelinating Polyneuropathies
Muscle & Nerve 24:311-324, Saperstein,D.S.,et al, 2001
Acute Neuromuscular Respiratory Paralysis
JNNP 56:334-343, Hughes,R.A.C.&Bihari,D., 1993
Duplication of Part of Chromosome 17 is Commonly Associated with HMSN Type I (Charcot-Marie-Tooth Disease Type 1)
Ann Neurol 31:570-572, Hallam,P.J.,et al, 1992
Research Criteria for Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
AdHoc Subcommittee, Neurol 41:617-6181991., , 1991